All Stories

  1. Space: the final frontier?
  2. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies Wi...
  3. Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model
  4. Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology
  5. Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish
  6. The effects of exercise training on cardiac matrix metalloproteinases activity and cardiac function in mice with diabetic cardiomyopathy
  7. Cardiovascular risk in high-hazard occupations: the role of occupational cardiology
  8. The Interplay between Myocardial Fibrosis, Strain Imaging and Collagen Biomarkers in Adults with Repaired Tetralogy of Fallot
  9. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of...
  10. Elucidating Carfilzomib’s Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin
  11. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
  12. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
  13. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
  14. Myospryn deficiency leads to impaired cardiac structure and function and schizophrenia-associated symptoms
  15. The European Association of Preventive Cardiology Aviation and Occupational Cardiology Task Force
  16. Is ARIS (aerobic/resistance/inspiratory muscle training) the optimal exercise training programme for chronic heart failure patients?
  17. Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress
  18. Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European H...
  19. Future of preventive cardiology: EAPC vision 2020–22
  20. Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European H...
  21. Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy
  22. Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era
  23. Cyclic stroke mortality variations follow sunspot patterns
  24. Desmin is essential for the structure and function of the sinoatrial node: implications for increased arrhythmogenesis
  25. Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of ...
  26. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II)
  27. Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase
  28. Correction: Diverse radiofrequency sensitivity and radiofrequency effects of mobile or cordless phone near fields exposure in Drosophila melanogaster
  29. Do we have to reconsider the guidelines for exercise intensity determination in cardiovascular rehabilitation?
  30. Regional differences in exercise training implementation in heart failure: findings from the Exercise Training in Heart Failure (ExTraHF) survey
  31. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose dependent manner: Implications for inotropy
  32. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis
  33. The importance of return to work: How to achieve optimal reintegration in ACS patients
  34. Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure
  35. Cardiovascular Anatomy and Physiology: Basic Principles and Challenges
  36. Amelioration of desmin network defects by αB-crystallin overexpression confers cardioprotection in a mouse model of dilated cardiomyopathy caused by LMNA gene mutation
  37. Molecular mechanisms of Carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of Metformin
  38. Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Associat
  39. Exercise training for chronic heart failure (ExTraMATCH II): Why all data are not equal
  40. Thrombolysis in Acute Lower Limb Ischemia: Review of the Current Literature
  41. Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials
  42. Combined Type III and Type II Endoleaks after Endovascular Aneurysm Repair: Presentation of 2 Cases and a Literature Review
  43. Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure
  44. Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group
  45. OP91 Individual Participant Data Meta-Analysis Of Exercise Rehabilitation In Heart Failure
  46. Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects
  47. Seeking best practices for cardiac rehabilitation registries in Europe
  48. Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy model
  49. Corrigendum to “Exercise-based cardiac rehabilitation in twelve European countries: Results of the European Cardiac Rehabilitation Registry” [Int. J. Cardiol. 228 (2017) 58–67]
  50. Impaired calcium homeostasis is associated with sudden cardiac death and arrhythmias in a genetic equivalent mouse model of the human HRC-Ser96Ala variant
  51. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concep...
  52. Determining exercise training responders through inflammatory status in heart failure
  53. Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule
  54. Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry
  55. Frailty and cardiac rehabilitation: A call to action from the EAPC Cardiac Rehabilitation Section
  56. The Rehabilitation Outcome Study - CROS
  57. Desmin and αB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival
  58. A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study
  59. Peptide-Drug Conjugate GnRH-Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth
  60. Hemodynamic effects of high intensity interval training in COPD patients exhibiting exercise-induced dynamic hyperinflation
  61. Elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques: association with p53 activation and disease severity
  62. Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18
  63. Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy
  64. Ischaemic preconditioning preserves antioxidant enzyme activity and reduces cell damage of in vivo rat hearts undergoing acute ischaemia
  65. Challenges in secondary prevention of cardiovascular diseases
  66. 0161: The neuroprotective agent rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction
  67. Diverse Radiofrequency Sensitivity and Radiofrequency Effects of Mobile or Cordless Phone near Fields Exposure in Drosophila melanogaster
  68. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
  69. P687Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy
  70. P637Desmin null mouse as a possible experimental model of arrhythmogenic cardiomyopathy
  71. Cardiac autonomic nervous activity in adults with coarctation of the aorta late after repair
  72. Neurohormones, cytokines, and aortic function in children with repaired coarctation of the aorta
  73. Complement system modulation as a target for treatment of arrhythmogenic right ventricular dysplasia/cardiomyopathy
  74. Neurohormonal activity and vascular properties late after aortic coarctation repair
  75. Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining "Inflammatory" Macrophage Activation
  76. Neurohormonal and cytokine fluctuations following transcatheter closure for an atrial septal defect
  77. Early shear stress signaling on vascular endothelium by a modified partial carotid ligation model
  78. Regulation of adverse remodelling by osteopontin in a genetic heart failure model
  79. Local Hemodynamics and Intimal Hyperplasia at the Venous Side of a Porcine Arteriovenous Shunt
  80. Usefulness of Natriuretic Peptide Levels to Predict Mortality in Adults With Congenital Heart Disease
  81. Heart rate turbulence in adults with repaired tetralogy of Fallot
  82. Carotid Artery Motion Estimation From Sequences of B-Mode Ultrasound Images: Effect of Scanner Settings and Image Normalization
  83. Local hemodynamics and intimal hyperplasia at the venous side of porcine carotid artery - Jugular vein shunt
  84. Desmin mediates TNF-α–induced aggregate formation and intercalated disk reorganization in heart failure
  85. Psychological consequences among adults following the 1999 earthquake in Athens, Greece
  86. Heart transplantation in heart failure: The prognostic importance of body mass index at time of surgery and subsequent weight changes
  87. Assessment of the classification capability of prediction and approximation methods for HRV analysis
  88. Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes
  89. Statin use and survival in patients with chronic heart failure — results from two observational studies with 5200 patients
  90. Extramatch: exercise training meta analysis of trails in chronic heart failure patients: effect of concomitant drug therapy
  91. Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure
  92. Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue
  93. Review: exercise training delays death and hospital admission in chronic heart failure
  94. 498 Impaired cardiopulmonary exercise function late after tetralogy of Fallot repair. Contributory factors
  95. 876-6 Exercise training meta-analysis of trials in chronic heart failure patients (ExTraMATCH)
  96. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)
  97. The relationship between cholesterol and survival in patients with chronic heart failure
  98. Global Impairment of Cardiac Autonomic Nervous Activity Late After the Fontan Operation
  99. 355 Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandin in reflex ventilatory control
  100. Uric Acid and Survival in Chronic Heart Failure: Validation and Application in Metabolic, Functional, and Hemodynamic Staging
  101. Skeletal Muscle Hypothesis in Heart Failure: Potential Triggers of Ergoreflex Stimulation
  102. Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity
  103. Muscle Metaboreflex-Induced Increases in Stroke Volume
  104. Skeletal Muscle Reflex in Heart Failure Patients: Role of Hydrogen
  105. Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure: A Putative Role for Prostaglandins in Reflex Ventilatory Control
  106. Lean tissue-adjusted versus body weight-adjusted peak oxygen consumption and mortality prediction in chronic heart failure
  107. Impaired left ventricular filling predicts augmented ventilatory response to exercise in patients with chronic heart failure
  108. Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old
  109. HIGH TUMOUR NECROSIS FACTOR-α LEVELS ARE ASSOCIATED WITH EXERCISE INTOLERANCE AND NEUROHORMONAL ACTIVATION IN CHRONIC HEART FAILURE PATIENTS
  110. Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance
  111. Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance : Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis
  112. Body mass index, obesity, and cachexia vs survival in chronic heart failure: Results from the ELITE 2 study Stefan D. Anker, Constantinos H. Davos, Darrel Francis, Robert Segal, Emanuela Santoro, Philip A. Poole-Wilson, Bertram Pitt, Andrew J. S. Coats...
  113. High tumor necrosis factor levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients Mariantonietta Cicoira, Aidan Bolger, Wolfram Doehner, Mathias Rauchhaus, Constantinos Davos, Rakesh Sharma, Faisa...
  114. Hyperleptinemia in chronic heart failure relates to growth hormone binding protein in male patients with and without cardiac cachexia Wolfram Doehner, Mathias Rauchhaus, Karl Egerer, Claus D. Pflaum, Christian J. Strasburger, Constantinos H. Davos, And...
  115. Serum total cholesterol, high-density lipoprotein, and prognosis in patients with chronic heart failure Mathias Rauchhaus, Wolfram Doehner, Constantinos H. Davos, Rakesh Sharma, Aidan Bolger, Heike Gabriel, Michael Kemp, Andrew J. S. Coats, Stefan D. A...
  116. Endotoxin and severity of chronic heart failure Mathias Rauchhaus, Wolfram Doehner, Aidan Bolger, Rakesh Sharma, Hendrik Schmidt, Constantinos Davos, Michael Kemp, Andrew J. S. Coats, Stefan D. Anker. NHLI, Clinical Cardiology, London, United Kingdom, ...
  117. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
  118. Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts
  119. Carotid Artery Motion Estimation from Sequences of B-mode Ultrasound Images: Effect of Dynamic Range and Persistence